Effect of preemptive analgesia with exoricoxib on early postoperative rehabilitation in patients with total hip and knee arthroplasty

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026176

Enrollment

Unknown

Registered

2019-09-24

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip and knee pain

Interventions

1:take Etoricoxib before surgery

2:take Etoricoxib after surgery

Eligibility

Sex/Gender

All

Age

30 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. due to hip/knee joint pain hospitalization for joint replacement; 2. conservative treatment is invalid; 3. patient's physical condition can tolerate surgery.

Exclusion criteria

Exclusion criteria: 1. patients with severe cardiac insufficiency (NYHA cardiac function classification II-IV); 2. active peptic ulcer/bleeding, or repeated ulcers/bleeding; 3. taking aspirin or other non-steroidal anti-inflammatory drugs After induction of asthma, urticaria or allergic reactions; 4. diagnosed ischemic heart disease, peripheral arterial disease.

Design outcomes

Primary

Measure	Time frame
vas;	—

Secondary

Measure	Time frame
hip /knee function score;adverse reaction;	—

Countries

China

Contacts

Public ContactSun Yu

Northern Jiangsu People's Hospital

docsunyu@163.com+86 18051060619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026